A coalition of conservative and activist organizations has petitioned FDA Commissioner Dr. Marty Makary to intervene in the sale of counterfeit and potentially unsafe weight loss medications. The groups are particularly concerned about products originating from Chinese manufacturers that are being sold directly to consumers without prescriptions.
The coalition also raised alarms about the misuse of the FDA’s “greenlist,” which they say is being exploited by some manufacturers in China to facilitate the import of these drugs. They warn that this practice could pose significant health risks to consumers.
**Why this matters**
Weight loss drugs that bypass regulatory safeguards can lead to serious health complications. Ensuring that medications meet safety standards and are dispensed appropriately is critical to protecting public health. The FDA’s role in regulating imports and verifying drug authenticity is essential in preventing the circulation of counterfeit products.
Source: NewsData